Document is current
Any future updates will be listed below
-
Authors
Atreya, Mihir R.
Cvijanovich, Natalie Z.
Fitzgerald, Julie C.
Weiss, Scott L.
Bigham, Michael T.
Jain, Parag N.
Schwarz, Adam J.
Lutfi, Riad
Nowak, Jeffrey
Allen, Geoffrey L.
Thomas, Neal J.
Grunwell, Jocelyn R.
Baines, Torrey
Quasney, Michael
Haileselassie, Bereketeab
Lindsell, Christopher J.
Alder, Matthew N.
Wong, Hector R.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK119463)
National Institute of Child Health and Human Development (R01HL161362, RL1HD107776, R00HD099387)
National Heart, Lung, and Blood Institute (K23HL151897)
National Institute of General Medical Sciences (R35 GM126943, R35 GM126943)
- License Information
-
More Information
Article History
Received: 8 May 2022
Accepted: 21 June 2022
First Online: 11 July 2022
Declarations
:
: Informed consent was obtained from parent or guardian of patients. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review boards of participating institutions and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: M.R.A., H.R.W, and Cincinnati Children’s Hospital Medical Center hold a provisional patent for the PERSEVEREnce risk model detailed in this manuscript.
